Lextemy

Medicinal product

(Invented) name

Lextemy

Active substance (s)

Bevacizumabas

Strength

25 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FG01, Bevacizumab

Marketing authorisation holder

Mylan IRE Healthcare Limited, Airija

Date of authorisation

2021-04-21

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Concentrate for solution for infusion	1 mg
Bevacizumabas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106376	92477	1092477	flakonas	4 ml N1		Receptinis	EU/1/20/1516/001	Netiekiama	-	-	No	-	-
106377	92478	1092478	flakonas	4 ml N5		Receptinis	EU/1/20/1516/002	Netiekiama	-	-	No	-	-
106378	92479	1092479	flakonas	16 ml N1		Receptinis	EU/1/20/1516/003	Netiekiama	-	-	No	-	-
106379	92480	1092480	flakonas	16 ml N2		Receptinis	EU/1/20/1516/004	Netiekiama	-	-	No	-	-
106380	92481	1092481	flakonas	16 ml N3		Receptinis	EU/1/20/1516/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-06-21	Išregistruotas
2021-04-21	Registruotas